Advancing Therapies for Patients

Find a clinical trial

page image

News

shadow image

Text Size

minus image

plus image

plus image

Print

Print image

Email a Friend

You are here: SCRI-UK

/News

News

Find a clinical trial

20 January 2017

Dr Uccello to present at ASCO GI Symposium

Sarah Cannon Research Institute UK’s Drug Development Unit is proud to announce  that ...

hero1 image

03 October 2016

Dr. Moschetta to present at ESMO Congress

Sarah Cannon Research Institute UK’s Drug Development Unit is proud to announce that Clinical ...

hero1 image

30 October 2015

Dr Mak Poster at NCRI Conference

SCRI UK is proud to announce that Dr Gabriel Mak, one of our Clinical ...

hero1 image

15 October 2015

Four Abstracts at ECCO from SCRI UK - UPDATED

SCRI UK is proud to announce four abstracts from Executive Medical Director Dr ...

hero1 image

29 January 2015

Sarah Cannon and Syapse Launch Precision Oncology Clinical Service to Expand Targeted Treatment Options for Patients

NASHVILLE, Tenn., and PALO ALTO, Calif., January 29, 2015  – Sarah Cannon, the ...

hero1 image

25 October 2014

Leading Article: Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies

Published in Drugs.  2014 Oct 25.   Shih K,  Arkenau HT , Infante ...

hero1 image

08 October 2014

Britain’s newest Radiotherapy Centre opens at Guy’s Hospital campus in London

The London Radiotherapy Centre  is first in the UK with ...

hero1 image

22 May 2014

SCRI at 2014 ASCO® Annual Meeting

Sarah Cannon Research Institute has 74 abstracts accepted for presentation at the 2014 ...

hero1 image

07 April 2014

SARAH CANNON RESEARCH INSTITUTE PRESENTS 10 CLINICAL TRIALS AT THE 105th ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

NASHVILLE, TN, April 7, 2014 – Sarah Cannon Research Institute (SCRI) announced today that ...

hero1 image

26 February 2014

SARAH CANNON BLOOD CANCER NETWORK PROMINENT AT BLOOD AND MARROW TRANSPLANT MEETINGS

NASHVILLE, TN, February 26, 2014 – The Sarah Cannon Blood Cancer Network ...

hero1 image

06 December 2013

SARAH CANNON RESEARCH INSTITUTE TO PRESENT 37 CLINICAL TRIALS AT THE 55th ANNUAL AMERICAN SOCIETY OF HEMATOLOGY MEETING

NASHVILLE, TN, December 6, 2013 – Sarah Cannon Research Institute (SCRI) ...

hero1 image

25 November 2013

T-DM1 (Kadcyla) approved in EU !

Earlier in the year, we told you Kadcyla (trastuzumab emtansine or T-DM1), ...

hero1 image

05 November 2013

SCRI UK Presenting at National Cancer Research Institute (NCRI) Cancer Conference 2013

SCRI UK is proud to have three presentations at this month’s NCRI Cancer ...

hero1 image

04 November 2013

Keep on Running !

As we told you last month ,  Dr Simon Chowdhury , one ...

hero1 image

02 October 2013

Expansion at SCRI UK - Join Our Team !

As we continue to grow, we are looking to expand our team at SCRI ...

hero1 image

12 September 2013

Research biopsies in the context of early phase oncology studies: clinical and ethical considerations

The Personalized Medicine approach in oncology is a direct result of an improved understanding ...

hero1 image

01 September 2013

SCRI UK Investigators Running Royal Parks Half Marathon

Dr Simon Chowdhury , one of SCRI UK's principal investigators , and ...

hero1 image

01 July 2013

Sarah Cannon Research Institute and AstraZeneca Announce Personalized Medicine Partnership and Enhanced Strategic Clinical Development Collaboration

NASHVILLE, TN and WILMINGTON, DE, July 1, 2013 – Sarah Cannon Research Institute ...

hero1 image

30 May 2013

SCRI to present a record number of abstracts at the 2013 ASCO® Annual Meeting

Sarah Cannon Research Institute (SCRI)   announced today that the  American Society ...

hero1 image

09 May 2013

Bringing The 2013 ASCO® Annual Meeting Highlights Directly To You From Chicago !

The Association of Cancer Physicians (ACP) is bringing you the latest oncology data from ...

hero1 image

06 May 2013

ITV News: Genetic profile testing to improve NHS cancer care

"Cancer patients across England will soon be offered a new type of gene ...

hero1 image

29 April 2013

New Genetic Sequencing Lab Creates “Tipping Point” for Personalised Cancer Care In UK

LONDON, UK, April. 29, 2013 - A new genetic profiling laboratory that will pioneer ...

hero1 image

22 February 2013

Great news for our patients - T-DM1 approved

FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate for Treating Her2-Positive ...

hero1 image

Latest Videos

watch the latest videos.

Learn more

News

news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals
LOC